This seemed a lot like you trying to stir the pot, but I'll bite. I think Ariad will present many opportunities for a good short along the way, but over the next few years patient shareholders should be rewarded (IMO).
How about one of your favorite friendly wagers? Let's say a one year Ihub subscription.